Lab-on-the-Needles: A Microneedle Patch-Based Mobile Unit for Highly Sensitive <i>Ex Vivo</i> and <i>In Vivo</i> Detection of Protein Biomarkers.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 39763125.
- Also identified by DOI 10.1021/acsnano.4c11238 and PMC identifier 11781025.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Detection of biomarkers associated with physiological conditions provides critical insights into healthcare and disease management. However, challenges in sampling and analysis complicate the detection and quantification of protein biomarkers within the epidermal layer of the skin and in viscous liquid biopsy samples. Here, we present the "Lab-on-the-Needles" concept, utilizing a microneedle patch-based sensing box (MNP-based SenBox) for mobile healthcare applications. This system facilitates the rapid capture of protein biomarkers directly from the <i>in situ</i> epidermal layer of skin or liquid biopsies, followed by on-needle analysis for immediate assessment. The integration of horseradish peroxidase-incorporated zeolitic imidazolate framework-8 (HRP@ZIF-8) as a sensitive and stable signal probe, the detection limit for anti-SARS-CoV-2 NP IgA antibodies and various SARS-CoV-2 S1P mutant strains improves by at least 1,000-fold compared to FDA-approved commercial saliva lateral flow immune rapid tests. Additionally, the MNP-based SenBox demonstrated minimally invasive monitoring and rapid quantification of inflammatory cytokine levels (TNF-α and IL-1β) in rats within 30 min using a portable ColorReader. This study highlights the potential of the MNP-based SenBox for the minimally invasive collection and analysis of protein biomarkers directly from <i>in situ</i> epidermal layers of skin or liquid biopsies that might facilitate mobile healthcare diagnostics and longitudinal monitoring.
Medical subject headings
- Needles
- COVID-19